Abstract:
The invention relates to a double network hydrogel comprising a polymer (A) having a persistence length between 10 and 1000 nm; a flexible polymer (B), wherein the persistence length is measured according to single molecule force microscopy measurement, wherein polymer (B) has an extended coil conformation at a first condition and a collapsed globular conformation at a second condition. Polymer (A) preferably is a polyisocyanate, while polymer (B) is a crosslinked flexible polymer like for example PNIPAM. The invention also relates to a method for making a double network hydrogel.
Abstract:
Disclosed are geminoid peptide-like compound according to Formula (I): R 1 - C(=0) - Z n - NR 3 - R 2 in which R 1 and R 2 are each independently saturated, partly saturated or unsaturated, straight, branched or cyclic alkyl chains, wherein R 1 has a number of C atoms of 11 or more, preferably 11 to 19, and R 2 has a number of C atoms of 12 or more, preferably 12 to 20; R3 is hydrogen or C 1 -C- 6 alkyl; n is an integer from 1 - 15; each Z independently is an amino acid residue, wherein Z n comprises an N- terminus attached to C(=0) and a C-terminus that is attached to NR 3 , for use as a medicament.
Abstract:
The invention relates to a process for the preparation of beads comprising a biocompatible hydrophobic polymer, a perfluorocarbon, polyvinylalcohoi and optionally a metal compound, comprising the steps of: a) adding the perfluorocarbon and optionally the metal compound to a solution of the biocompatible hydrophobic polymer in a polar solvent to provide a first liquid mixture, b) adding the first liquid mixture to an aqueous solution of a biocompatible surfactant comprising polyvinylalcohoi under sonication to obtain a second liquid mixture, c) maintaining the sonication of the second liquid mixture while cooling, d) evaporating the polar solvent from the second liquid mixture to obtain a suspension of beads comprising the biocompatible hydrophobic polymer, the perfluorocarbon and optionally the metal compound, e) separating the beads from the suspension and preparing a water suspension of the beads and f) freeze-drying the water suspension to obtain the beads, wherein the addition of the first liquid mixture to the biocompatible surfactant in step b) is performed within a period of at most seconds, wherein the sonication in step b) and the sonication in step c) are performed directly into the liquid mixtures by for example a probe or flow sonicator at an amplitude of at least 120 μm for 0.01-10 minutes and wherein the weight ratio of the biocompatible surfactant to the biocompatible hydrophobic polymer is at least 3:1. The invention further relates to beads having close F-H20 interactions, which are suitable for imaging purposes.
Abstract:
The present invention relates to a new genetically attenuated, live organism against malaria. The present invention further relates to a pharmaceutical composition comprising such live attenuated organism. The present invention further relates to methods of treatment and/or prevention using such live attenuated organism.
Abstract:
This invention is in the field of medical treatments. It provides means and methods for the prevention and treatment of cystic renal and liver diseases, in particular renal diseases caused by lithium. More in particular it provides a method for the treatment or prevention of nephrogenic diabetes insipidus by administering a specific carbonic anhydrase 9 and or 12 inhibitor to a subject in need of such a treatment.
Abstract:
The present invention is in the field of a magneto optical device comprising a magnetic unit and an optical unit, an electronic device comprising the magneto-optic device, a method of energy saving using the magneto- optical device, an array comprising the magneto-optical devices, and a method of changing magnetic orientation.
Abstract:
An ultrasound transducer system. The system includes at least three ultrasound transducer arrays including a central transducer array and at least two lateral transducer arrays located adjacent the central transducer array, wherein the at least three ultrasound transducer arrays are arranged such that ultrasound beam paths of the at least three ultrasound transducer arrays overlap in an approximately planar location.
Abstract:
The invention provides a rapid cycle dynamic nuclear polarization (DNP) NMR apparatus (100) comprising (i) a cooling unit (10), configured to cool a sample (70) in a capillary (60), (b) a DNP polarization unit (20) configured to polarize the sample (70) in the capillary (60), (c) a stripline-based NMR detector (30) comprising a stripline (32) for NMR analysis of the sample (70) in the capillary (60), (d) a transport unit (40) configured to guide the capillary (60) from the DNP polarization unit (20) to the stripline (32) of stripline-based NMR detector (30); and (e) a heating unit (50) configured to heat the sample (70) in the capillary (60) before analysis of the sample (70) by the stripline-based NMR detector (30). Fast (1D-3D) NMR measurements with high resolution may be obtained.
Abstract:
Automatic tracheostoma speech valve (ATSV) fixation brace, comprising a fixation part (2) for keeping an ATSV base element (8) in position during use, and a holding part (3) for holding the ATSV fixation brace (1) to a patient, wherein at least the holding part (3) comprises a thermoplastic material, the thermoplastic material being moldable to the local anatomic shape of the patient.
Abstract:
Patient mobile computing system (1) and method for predicting exacerbations in a patient illness related status. The method comprises collecting patient sensor data using sensors (8), and executing a local prediction model. The local prediction model comprising a Bayesian network (6) to obtain a probability of an exacerbation of a patient status. The Bayesian network (6) receives patient input data, patient sensor data, and providing probability data,and the local prediction model provides guidance data based on the probability data. The local prediction model (6) is implemented both in a portable device (1), such as a smart phone, and in a centralized patient data processing system (20).